Liat Shargian

711 total citations
51 papers, 452 citations indexed

About

Liat Shargian is a scholar working on Hematology, Oncology and Infectious Diseases. According to data from OpenAlex, Liat Shargian has authored 51 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 20 papers in Oncology and 9 papers in Infectious Diseases. Recurrent topics in Liat Shargian's work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Liat Shargian is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Acute Myeloid Leukemia Research (10 papers) and Multiple Myeloma Research and Treatments (7 papers). Liat Shargian collaborates with scholars based in Israel, United States and Italy. Liat Shargian's co-authors include Pia Raanani, Moshe Yeshurun, Anat Gafter‐Gvili, Ronit Gurion, Ron Ram, Dafna Yahav, Ofir Wolach, Odelia Amit, Oren Pasvolsky and Uri Rozovski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Liat Shargian

47 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liat Shargian Israel	14	168	155	73	69	58	51	452
Yael Bar‐On Israel	12	180 1.1×	125 0.8×	27 0.4×	68 1.0×	49 0.8×	26	502
Simon Cronin United States	12	97 0.6×	164 1.1×	31 0.4×	55 0.8×	43 0.7×	23	500
Hana Golan Israel	12	57 0.3×	46 0.3×	28 0.4×	60 0.9×	58 1.0×	32	405
Özlem Tüfekçi Türkiye	12	48 0.3×	76 0.5×	26 0.4×	59 0.9×	6 0.1×	51	334
Paola Muggeo Italy	12	61 0.4×	32 0.2×	22 0.3×	40 0.6×	18 0.3×	40	382
Frédérick Durand United States	9	32 0.2×	65 0.4×	20 0.3×	24 0.3×	28 0.5×	31	333
Fatih Erbey Türkiye	10	45 0.3×	76 0.5×	36 0.5×	29 0.4×	6 0.1×	42	338
Luca Manfredini Italy	11	55 0.3×	88 0.6×	11 0.2×	19 0.3×	48 0.8×	24	308
Xiaomin Cheng China	10	41 0.2×	28 0.2×	15 0.2×	176 2.6×	29 0.5×	24	409
L Vaillant France	11	28 0.2×	56 0.4×	41 0.6×	52 0.8×	225 3.9×	43	556

Countries citing papers authored by Liat Shargian

Since Specialization

Citations

This map shows the geographic impact of Liat Shargian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liat Shargian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liat Shargian more than expected).

Fields of papers citing papers by Liat Shargian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liat Shargian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liat Shargian. The network helps show where Liat Shargian may publish in the future.

Co-authorship network of co-authors of Liat Shargian

This figure shows the co-authorship network connecting the top 25 collaborators of Liat Shargian. A scholar is included among the top collaborators of Liat Shargian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liat Shargian. Liat Shargian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gurion, Ronit, Pia Raanani, Iuliana Vaxman, et al.. (2024). Role of Autologous Transplant in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Triplets: A Systematic Review and Meta-Analysis. Acta Haematologica. 148(4). 468–476. 2 indexed citations

Kastritis, Efstathios, Giovanni Palladini, Paolo Milani, et al.. (2023). Venetoclax in Relapse/Refractory AL Amyloidosis—A Multicenter International Retrospective Real-World Study. Cancers. 15(6). 1710–1710. 16 indexed citations

Goldberg, Idan, Galit Granot, Alona Telerman, et al.. (2023). Extracorporeal photopheresis induces NETosis in neutrophils derived from patients with chronic graft‐vs‐host disease. Journal of Clinical Apheresis. 38(5). 615–621. 2 indexed citations

Yeshurun, Moshe, Liat Shargian, Oren Pasvolsky, et al.. (2023). Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey. Bone Marrow Transplantation. 58(4). 414–423. 7 indexed citations

Shargian, Liat, Odelia Amit, Hanna Bernstine, et al.. (2022). The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission—A retrospective multicenter study. European Journal Of Haematology. 110(2). 149–156. 2 indexed citations

Shargian, Liat, Pia Raanani, Moshe Yeshurun, Anat Gafter‐Gvili, & Ronit Gurion. (2022). Chimeric antigen receptor T‐cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis. British Journal of Haematology. 198(5). 838–846. 22 indexed citations

Shargian, Liat, Pia Raanani, Moshe Yeshurun, Anat Gafter‐Gvili, & Ronit Gurion. (2022). CAR‐T cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis. British Journal of Haematology. 200(1). e4–e5. 6 indexed citations

Shargian, Liat, Mical Paul, Lior Nesher, et al.. (2022). Outcomes of neutropenic hemato-oncological patients with viridans group streptococci (VGS) bloodstream infection based on penicillin susceptibility. European Journal of Clinical Microbiology & Infectious Diseases. 42(2). 177–182. 1 indexed citations

Ram, Ron, Sigal Grisariu, Liat Shargian, et al.. (2021). A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study. Blood. 138(Supplement 1). 1733–1733.

10.

Shimony, Shai, Moshe Yeshurun, Ofir Wolach, et al.. (2021). Post-transplantation maintenance with sorafenib or midostaurin for FLT3 positive AML patients – a multicenter retrospective observational study. Leukemia & lymphoma. 62(10). 2475–2481. 3 indexed citations

11.

Pasvolsky, Oren, Liat Shargian, Uri Rozovski, et al.. (2021). Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantation. Leukemia & lymphoma. 62(11). 2747–2754. 5 indexed citations

12.

Pasvolsky, Oren, Shai Shimony, Moshe Yeshurun, et al.. (2021). Maintenance therapy after allogeneic hematopoietic transplant for acute myeloid leukemia: a systematic review and meta-analysis. Acta Oncologica. 60(10). 1335–1341. 12 indexed citations

13.

Shargian, Liat, Ofir Wolach, Uri Rozovski, et al.. (2020). Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia. Annals of Hematology. 99(12). 2939–2945. 1 indexed citations

14.

Yeshurun, Moshe, Uri Rozovski, Oren Pasvolsky, et al.. (2020). Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study. Blood Advances. 4(16). 3822–3828. 6 indexed citations

15.

Gafter‐Gvili, Anat, et al.. (2020). Obinutuzumab‐related adverse events: A systematic review and meta‐analysis. Hematological Oncology. 39(2). 215–221. 28 indexed citations

16.

Shargian, Liat, Anat Gafter‐Gvili, Haim Ben‐Zvi, et al.. (2019). Risk factors for mortality due to Acinetobacter baumannii bacteremia in patients with hematological malignancies – a retrospective study. Leukemia & lymphoma. 60(11). 2787–2792. 13 indexed citations

17.

Shargian, Liat, Dafna Yahav, Uri Rozovski, et al.. (2019). Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation – a single-center experience. Leukemia & lymphoma. 60(9). 2230–2236. 3 indexed citations

18.

Tau, Noam, Liat Shargian, Mical Paul, et al.. (2019). Reporting infections in clinical trials of patients with haematological malignancies. Clinical Microbiology and Infection. 25(12). 1494–1500. 13 indexed citations

19.

Raanani, Pia, David Lavie, Yulia Volchek, et al.. (2018). Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study. Clinical Lymphoma Myeloma & Leukemia. 18(7). e295–e301. 16 indexed citations

20.

Shargian, Liat, Ronit Gurion, Pia Raanani, Dafna Yahav, & Anat Gafter‐Gvili. (2018). Hypomethylating Agents-associated Infections—Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Lymphoma Myeloma & Leukemia. 18(9). 603–610.e1. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact